https://www.selleckchem.com/pr....oducts/msc2530818.ht
The prevalence of anti-TB drug-induced hepatotoxicity was 8%. Body mass index 18.5 Kg/m2 (AOR = 5.8 [95% CI 2.2-8.9]), low CD4 count (AOR = 4.9 [95% CI 1.6-15.8]), and the presence of comorbid illnesses (AOR = 3.9 [95% CI 1.7-8.9]) were identified as independent predictors of drugs-induced hepatotoxicity among Human Immunodeficiency Virus positive patients taking Isoniazid and rifapentine. The prevalence of anti-TB drug-induced hepatotoxicity was higher compared to standard references. BMI18 kg/m2, low CD4 count, and comorbid
Like
Comment
Share
